LGOct 1, 2025

Predicting Diabetic Retinopathy Using a Two-Level Ensemble Model

arXiv:2510.01074v11 citationsh-index: 1
Originality Incremental advance
AI Analysis

This addresses the problem of resource-intensive diagnosis for diabetic patients, though it appears incremental as it builds on existing ensemble techniques.

The paper tackled early detection of diabetic retinopathy by developing a non-image-based two-level ensemble model using routine laboratory tests, achieving accuracy of 0.9433 and ROC-AUC of 0.9844, which outperformed baseline methods.

Preprint Note: This is the author preprint version of a paper accepted for presentation at the IISE Annual Conference & Expo 2025. The final version will appear in the official proceedings. Diabetic retinopathy (DR) is a leading cause of blindness in working-age adults, and current diagnostic methods rely on resource-intensive eye exams and specialized equipment. Image-based AI tools have shown limitations in early-stage detection, motivating the need for alternative approaches. We propose a non-image-based, two-level ensemble model for DR prediction using routine laboratory test results. In the first stage, base models (Linear SVC, Random Forest, Gradient Boosting, and XGBoost) are hyperparameter tuned and internally stacked across different configurations to optimize metrics such as accuracy, recall, and precision. In the second stage, predictions are aggregated using Random Forest as a meta-learner. This hierarchical stacking strategy improves generalization, balances performance across multiple metrics, and remains computationally efficient compared to deep learning approaches. The model achieved Accuracy 0.9433, F1 Score 0.9425, Recall 0.9207, Precision 0.9653, ROC-AUC 0.9844, and AUPRC 0.9875, surpassing one-level stacking and FCN baselines. These results highlight the model potential for accurate and interpretable DR risk prediction in clinical settings.

Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes